The U.S. Food and Drug Administration today announced important steps to better support consumer access to hearing aids. The agency issued a guidance document explaining that it does not intend to enforce the requirement that individuals 18 and up receive a medical evaluation or sign a waiver prior to purchasing most hearing aids. This guidance is effective immediately. Today, the FDA is also announcing its commitment to consider creating a category of over-the-counter (OTC) hearing aids that could deliver new, innovative and lower-cost products to millions of consumers.
One Drop has announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance and Conformité Européene (CE) mark approval for One Drop | Chrome, a beautiful blood glucose monitoring system that marries modern design with advanced medical and mobile technology.
The RECHORD trial allows cardiovascular surgeons to replace damaged string-like tendons, called chordae, through a small incision while the heart is beating.
New medical technology is being utilized in a just-started clinical trial in patients with Alzheimer’s Disease.
Using state-of-the-art brain imaging technology, scientists at the National Institutes of Health filmed what happens in the brains of mice that developed cerebral malaria (CM).
Of all the drugs being discussed at this year’s meeting of the American Society of Hematology, one caught my attention. The new agent, a monoclonal antibody to CD22 with a toxin attached, is manufactured by Pfizer. It’s called inotuzumab ozogamicin. As that’s a mouthful, some doctors call it Ino.
It only works if we care about keeping the memory
Some hopeful news for those who can’t remember new people’s names: stimulating the brain with a magnetic pulse can bring back forgotten short-term memories, as long as we know that we’ll need that information later.
BTG International Canada Inc., a part of global specialist healthcare company BTG (LSE: BTG), has announced the commercial launch of DC Bead LUMI™ in Canada. Launch represents the first market commercialization of DC Bead LUMI™ in the world, with regulatory clearances and launches planned for additional markets worldwide.
People who consistently smoked an average of less than one cigarette per day over their lifetime had a 64 percent higher risk of earlier death than never smokers, and those who smoked between one and 10 cigarettes a day had an 87 percent higher risk of earlier death than never smokers, according to a new study from researchers at the National Cancer Institute (NCI).
A highly innovative, personalized cell-based treatment for a high-risk form of the most common childhood cancer continues to move through clinical trials.